In order to test the effects of estrogen on the clearance of cholesterol of dietary origin from the blood and its elimination from the body via the bile in an in vivo animal model, the fate of radioactivity from intravenously injected [3H]cholesterol-labeled chylomicrons was investigated in the rat. The labeled lipoproteins were administered intrajugularly to male rats previously given 17α ethinyl estradiol or the vehicle only, and the removal of the radioactivity from the blood and its uptake by the liver and secretion into bile was determined. Experiments were carried out in animals with or without prior drainage (20 hr) of the pool of bile acids in the enterohepatic circulation, to take account of the different demands of the liver for cholesterol in the two conditions. In rats without biliary drainage, estrogen treatment decreased the rate of removal of radioactivity from the blood by about 30% and the recovery of cholesterol in the liver by about 50% in the first 30 min after injection of the labeled chylomicrons. After biliary drainage, however, the recovery of label in the liver after 90 min was similar in estrogen-treated and control animals, although its secretion into bile was markedly reduced in the estrogen-treated group (total biliary secretion in 90 min was 26% of the value found in control rats). In addition, the apolipoprotein E (aopE) content of the serum total lipoproteins was markedly reduced by estrogen. These results provide direct evidence indicating that estrogen retards the elimination of dietary cholesterol from the body via the bile in the rat, and this is likely to be mainly due to a reduced level of apoE in chylomicrons. In view of this, we suggest that the hypothesis that estrogen increases the hepatic uptake of chylomicron cholesterol, and its excretion in the bile during contraceptive and hormone replacement therapy should be reexamined.
SacksFM, WalshBW. The effects of reproductive hormones on serum lipoproteins: Unresolved issues in biology and clinical practice. Multidisciplinary perspectives on menopause. Ann N Y Acad Sci592: 272–285, 1990.
3.
StamperMJ, ColditzGA. Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiological evidence. Prev Med20: 47–63, 1991.
4.
KnoppRH. Estrogen replacement therapy for reduction of cardiovascular risk in women. Curr Opin Lipidol2: 240–347, 1991.
5.
SullivanJM, Vander SwaagR, HughesJP, MaddockV, KroelzFW, RamanathanKB, MirvisDM. Estrogen replacement and coronary artery disease: Effect on survival in postmenopausal women. Arch Intern Med150: 2–7, 1990.
6.
HulleyS, GradyD, BushT, FurbergC, HerringtonD, RiggsB, VittinghoffE.Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and estrogen/progestin replacement study (HERS) research group. J Am Med Assoc280: 605–613, 1998.
7.
KushwahaRS. Female sex steroid hormones and lipoprotein metabolism. Curr Opin Lipidol3: 167–172, 1992.
8.
ChaoYS, WindierET, ChenGC, HavelRJ. Hepatic catabolism of rat and human lipoproteins in rats treated with 17α ethinyl estradiol. J Biol Chem254: 11360–11366, 1979.
9.
WindlerET, KovanenPT, ChaoYS, BrownMS, HavelRJ, GoldsteinJL. The estradiol-stimulated lipoprotein receptor of rat liver. J Biol Chem255: 10464–10471, 1980.
10.
MaPTS, YamamotoT, GoldsteinJL, BrownMS. Increased mRNA follow density lipoprotein receptor in livers of rabbits treated with 17α: ethinyl estradiol. Proc Natl Acad Sci USA83: 792–796, 1986.
11.
HandleyDA, ArbeenyCM, EdeHA, ChienS.Hepatic binding and internalization of low density lipoprotein-gold conjugates in rats treated with 17α ethinyl estradiol. J Cell Biol90: 778–787, 1981.
RohlmannA, GotthardtM, HammerRE, HerzJ.Inducible inactivation of hepatic LRP gene by cre-mediated recombination confirms role of LRP in clearance of chylomicron remnants. J Clin Invest101: 689–695, 1998.
15.
ChoiSY, FongLG, KirvenMJ, CooperAD. Use of an anti-low density lipoprotein receptor antibody to quantify the role of the LDL receptor in the removal of chylomicron remnants in the mouse in vivo. J Clin Invest88: 1173–1181, 1991.
16.
Van BerkelTJC, VoorschuurA, KuiperJ.β-Migrating very low density lipoproteins and chylomicron remnants bind to rat liver hepatocytes at a low-density-lipoprotein-independent site (the remnant receptor). Biochem J310: 359–360, 1995.
17.
WillnowTE, ShengZ, IshibashiS, HerzJ.Inhibition of hepatic chylomicron remnant uptake by gene transfer of a receptor antagonist. Science264: 1471–1474, 1994.
18.
BerrF, EckelRB, KernF.Contraceptive steroids increase hepatic uptake of chylomicron remnants in healthy young women. J Lipid Res27: 645–651, 1977.
van BeckAP, de Ruijter-HeijstekFC, ErkelensDW, deBruinTW. Menopause is associated with reduced protection from postprandial lipemia. Arterioscler Thromb Vasc Biol19: 2737–2741, 1999.
21.
KnoppHR, ZhuX, BonetB.Effects of estrogens on lipoprotein metabolism and cardiovascular disease in women. Atherosclerosis110:(Suppl):83–9l, 1994.
22.
KnoppRH. Cardiovascular effects of endogenous and exogenous sex hormones over a woman's lifetime. Am J Obstet Gynecol158: 1630–1643, 1988.
23.
BravoE, OrtuG, CantaforaA, LambertMS, AvellaM, MayesPA, BothamKM. Comparison of the hepatic uptake and processing of cholesterol from chylomicrons of different fatty acid composition in the rat in vivo. Biochim Biophys Acta1258: 328–336, 1995.
24.
NilssonA, ZilversmitB.Fate of intravenously administered particulate and lipoprotein cholesterol in the rat. J Lipid Res13: 32–38, 1972.
25.
BravoE, CantaforaA, CicchiniC, AvellaM, BothamKM. The influence of estrogen on hepatic cholesterol metabolism and biliary lipid secretion in rats fed fish oil. Biochim Biophys Acta1437: 367–377, 1999.
26.
RodriguezJV, TorresAM, LunazziG, TiribelliC.Effect of ethinyl estradiol and epomediol on bile flow and biliary lipid composition in rat. Biochem Pharmacol43: 1289–1293, 1992.
27.
LambertMS, BothamKM, MayesPA. Modification of the composition of dietary oils and fats upon incorporation into chylomicron remnants. Br J Nutr76: 435–445, 1996.
28.
MindhamMA, MayesPA, MillerNE. Reverse cholesterol transport in the isolated perfused rat spleen. Biochem J268: 499–505, 1990.
29.
MindhamMA, MayesPA. A simple and rapid method for the preparation of apolipoproteins fro electrophoresis. J Lipid Res33: 1084–1088, 1992.
30.
LaemmliUK. Cleavage of structural protein during assembly of the head of bacteriophage T4. Nature227: 680–685, 1970.
31.
GleesonJM, DukesCS, ElstadNL, ChamIF, WilsonDE. Effects of estrogen: progestin agents on plasma retinoid and chylomicron remnant metabolism. Contraception35: 69–78, 1987.
32.
KnoppHR. The effects of oral contraceptives and postmenopausal estrogens on lipoprotein physiology and atherosclerosis. In: HalbeHW, RekersH, Eds. Oral Contraception. Carnforth, Lanes, UK: Parthenon Publishing Group, pp 31–45, 1990.
33.
SzantoA, BalasubramaniamS, RoachPD, NestelPJ. Modulation of the low-density-lipoprotein-receptor-related protein and its relevance to chylomicron remnant metabolim. Biochem J288: 791–794, 1992.
34.
BravoE, CantaforaA, DeLucaV, TripodiM, AvellaM, MayesPA, BothamKM. Comparison of the uptake and processing of cholesterol from chylomicrons of different fatty acid composition in rats fed high and low fat diets. Eur J Biochem246: 92–102, 1997.
35.
MamoJCL. Atherosclerosis is a post-prandial disease. Endocrinol Metab2: 229–244, 1995.
36.
ArbeenyCM, RificiVA. The uptake of chylomicron remnants and very low density lipoprotein remnants by the perfused rat liver. J Biol Chem259: 9662–9666, 1984.
37.
WadeDP, SoutarAK, GibbonsGF. Independent regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase and chylomicron remnant receptor activities in rat liver. Biochem J218: 203–211, 1984.
38.
RedgraveTG. Formation and metabolism of chylomicrons. Int Rev Physiol28: 103–130, 1984.
39.
CantaforaA, BravoE, YanCC. Characterisation of lipoprotein fractions isolated from plasma of male Wistar rats by gradient ultracentrifugation. Proc Soc Exp Biol Med204: 90–95, 1993.
40.
ErikssonM, AngelinB, HenrikssonP, EricssonS, VitolsS, BerglundL.Metabolism of lipoprotein remnants in humans. Studies during intestinal infusion of fat and cholesterol in subjects with varying expression of the low density lipoprotein receptor. Arterioscler Thromb11: 827–837, 1991.
41.
HerzJ, QuiSQ, OesterleA, DeSilvaHV, ShafiS, HavelRJ. Initial hepatic removal of chylomicron remnants is unaffected but endocytosis is delayed in mice lacking the low density lipoprotein receptor. Proc Natl Acad Sci U S A92: 4611–4615, 1995.
42.
EisenbergS, SehayekE, OlivecronaT, VlodavskyI.Lipoprotein lipase enhances binding of lipoproteins to heparan sulfate on cell surfaces and extracellular matrix. J Clin Invest90: 2013–2021, 1992.
43.
JiZS, LauerSI, FazioS, BensadounA, TaylorJM, MahleyRW. Enhanced binding and uptake of remnant lipoproteins by hepatic lipase-secreting hepatoma cells in culture. J Biol Chem269: 13429–13436, 1994.
44.
BeisiegelU.New aspects on the role of plasma lipases on lipoprotein catabolism and atherosclerosis. Atherosclerosis124: 1–8, 1996.
45.
Applebaum-BowdenDM, McCleanP, SteinmetzA, FontanaD, MatthysC, WarnickGR, CheungM, AlbersJJ, HazzardWR. Lipoprotein, apolipoprotein, and lipolytic enzyme changes following estrogen administration in post-menopausal women. J Lipid Res30: 1895–1906, 1989.
46.
FieldingPE, FieldingCJ. Dynamics of lipoprotein transport in the circulatory system. In: VanceDE, VanceJ, Eds. Biochemistry of Lipids, Lipoproteins and Membranes. Amsterdam: Elsevier, pp 427–459, 1991.
BasdevantA.Steroids and lipid metabolism: Mechanism of action. Int J Fertil37:(Suppl 2):93–97, 1992.
49.
WakatsukiA, SagaraY.Effects of continuous medroxyprogesterone acetate on lipoprotein metabolism in postmenopausal women receiving oestrogen. Maturitas25: 35–44, 1996.
50.
KushwahaRS, FosterDM, BarrettPH, CareyKD, BernardMG. Metabolic regulation of plasma apolipoprotein E by estrogen and progesterone in the baboon (Papio sp.). Metabolism40: 93–100, 1991.
51.
KhokhaR, HuffMW, WolfeBM. Divergent effects of d-norgestrel on the metabolism of rat very low density and low density apolipoprotein B. J Lipid Res27: 699–705, 1986.
52.
BennionLJ, MoltDM, HowardBV. Oral contraceptives raise the cholesterol saturation of bile by increasing biliary cholesterol secretion. Metabolism29: 18–22, 1980.
53.
VoieM.Estrogen cholestasis: Metabolites or receptors?Gastroenterology93: 643–649, 1987.
54.
Del PozoR, NerviF, CovarubiasC, RoncoB.Reversal of progesterone-induced biliary cholesterol output by dietary cholesterol and ethinylestradiol. Biochim Biophys Acta753: 164–172, 1983.
55.
BonazziP, NovelliG, GaleazziR.Effect of chenodeoxycholic acid on the alterations of biliary lipid secretion induced by ethinyl estradiol in the rat. Br J Exp Pathol67: 341–348, 1986.
56.
BravoE, FloraL, CantaforaA, De LucaV, TripodiM, AvellaM, BothamKM. The influence of dietary saturated and unsaturated fat on hepatic cholesterol metabolism and the biliary excretion of chylomicron cholesterol in the rat. Biochim Biophys Acta1390: 134–148, 1998.
